Catalio Capital Management

Portfolio Co Investors 2026 for Catalio Capital Management: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Catalio Capital Management accounts for 38 tracked companies with verified cap-table data, 38 of which disclose round sizes totalling $6.2B. The median disclosed raise is $128M, and the largest is InSightec at $800M, ahead of Neumora Therapeutics ($500M) and Flourish ($500M).

The names that recur most often on these co-invested cap tables are Catalio Capital Management (38 companies), Alexandria Venture Investments (5 companies), Novo Holdings (5 companies), ARCH Venture Partners (4 companies), F-Prime Capital (4 companies), Casdin Capital (4 companies). By latest disclosed round, the market skews Series B (13), Series A (11), Series D (4), Seed (4).

Best funded Catalio Capital Management companies

  1. InSightec — $800M (latest: Growth)
  2. Neumora Therapeutics — $500M (latest: Series A)
  3. Flourish — $500M (latest: Growth)
  4. FogPharma — $323M (latest: Series D)
  5. SetPoint Medical — $220M (latest: Series D)
  6. Paige — $220M (latest: Series C)
  7. Avalyn Pharma — $211M (latest: Series B)
  8. Entos — $206M (latest: Series A)
  9. Lila Sciences — $200M (latest: Seed)
  10. GlycoEra — $179M (latest: Series B)
  11. Affini-T Therapeutics — $175M (latest: Seed)
  12. ProSomnus Sleep Technologies — $168M (latest: IPO)
  13. Superluminal Medicines — $158M (latest: Series A)
  14. Surface Oncology — $150M (latest: Series A)
  15. Clasp Therapeutics — $150M (latest: Series A)

Catalio Capital Management, LP — related firms and companies (56)

Catalio Capital Management, LP profile · All research reports